{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:20:24Z","timestamp":1787671224102,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2025A03J3818"],"award-info":[{"award-number":["2025A03J3818"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515013138"],"award-info":[{"award-number":["2024A1515013138"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015956","name":"Special Project for Research and Development in Key areas of Guangdong Province","doi-asserted-by":"publisher","award":["2022B1111020002"],"award-info":[{"award-number":["2022B1111020002"]}],"id":[{"id":"10.13039\/501100015956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92269108"],"award-info":[{"award-number":["92269108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.phymed.2025.157308","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:53:59Z","timestamp":1758772439000},"page":"157308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Astragaloside IV reduces hepatitis B surface antigen level via monocyte\/macrophages in chronic HBV infection mice"],"prefix":"10.1016","volume":"148","author":[{"given":"Mengling","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5173-1376","authenticated-orcid":false,"given":"Lifen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2970-9457","authenticated-orcid":false,"given":"Qinghong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7484-6891","authenticated-orcid":false,"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5628-3500","authenticated-orcid":false,"given":"Xinghua","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2025.157308_bib0001","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood.2020009166","article-title":"Targeting the anxa1\/fpr2\/alx pathway regulates neutrophil function, promoting thromboinflammation resolution in sickle cell disease","volume":"137","author":"Ansari","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2025.157308_bib0002","first-page":"39","article-title":"Traditional chinese medicine and related active compounds against hepatitis b virus infection","volume":"4","author":"Cui","year":"2010","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.phymed.2025.157308_bib0003","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.immuni.2016.02.026","article-title":"Phagocytosis: an immunobiologic process","volume":"44","author":"Gordon","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.phymed.2025.157308_bib0004","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1742-7843.2004.t01-1-pto950508.x","article-title":"Transport and bioavailability studies of astragaloside iv, an active ingredient in radix astragali","volume":"95","author":"Gu","year":"2004","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.phymed.2025.157308_bib0005","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1186\/s12967-024-05355-9","article-title":"Metabolomics combined with network pharmacology reveals a role for astragaloside iv in inhibiting enterovirus 71 replication via pi3k-akt signaling","volume":"22","author":"Hao","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phymed.2025.157308_bib0006","doi-asserted-by":"crossref","first-page":"e1309","DOI":"10.1002\/iid3.1309","article-title":"Astragaloside iv inhibits inflammation caused by influenza virus via reactive oxygen species\/nod-like receptor thermal protein domain associated protein 3\/caspase-1 signaling pathway","volume":"12","author":"Huang","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.phymed.2025.157308_bib0007","article-title":"Recent advances in drug delivery nanocarriers incorporated in temperature-sensitive pluronic f-127\u2013a critical review","volume":"72","author":"Jaquilin","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.phymed.2025.157308_bib0008","first-page":"22","article-title":"Toll-like receptor response to hepatitis b virus infection and potential of tlr agonists as immunomodulators for treating chronic hepatitis b: an overview","author":"Kayesh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2025.157308_bib0009","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41392-022-01028-5","article-title":"Dihydroartemisinin regulates immune cell heterogeneity by triggering a cascade reaction of cdk and mapk phosphorylation","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.phymed.2025.157308_bib0010","first-page":"28","article-title":"Pharmacological effects of astragaloside iv: a review","author":"Liang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.phymed.2025.157308_bib0011","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41575-022-00724-5","article-title":"The scientific basis of combination therapy for chronic hepatitis b functional cure","volume":"20","author":"Lim","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2025.157308_bib0012","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1136\/gutjnl-2022-327059","article-title":"Engineered anti-pdl1 with ifn\u03b1 targets both immunoinhibitory and activating signals in the liver to break hbv immune tolerance","volume":"72","author":"Meng","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.phymed.2025.157308_bib0013","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/labinvest.3700219","article-title":"Isolation, purification and flow cytometric analysis of human intrahepatic lymphocytes using an improved technique","volume":"85","author":"Morsy","year":"2005","journal-title":"Lab Invest."},{"key":"10.1016\/j.phymed.2025.157308_bib0014","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jhep.2024.02.017","article-title":"Single-cell landscape of functionally cured chronic hepatitis b patients reveals activation of innate and altered cd4-ctl-driven adaptive immunity","volume":"81","author":"Narmada","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2025.157308_bib0015","first-page":"13","article-title":"Clearance of pegylated interferon by kupffer cells limits nk cell activation and therapy response of patients with hbv infection","author":"Nishio","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phymed.2025.157308_bib0016","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5582\/ddt.2013.v7.6.212","article-title":"Traditional chinese medicine and related active compounds: a review of their role on hepatitis b virus infection","volume":"7","author":"Qi","year":"2013","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.phymed.2025.157308_bib0017","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0254-6272(13)60189-2","article-title":"Pharmacological effects of astragaloside iv: a literature review","volume":"33","author":"Ren","year":"2013","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.phymed.2025.157308_bib0018","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.immuni.2014.12.016","article-title":"The rna sensor rig-i dually functions as an innate sensor and direct antiviral factor for hepatitis b virus","volume":"42","author":"Sato","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.phymed.2025.157308_bib0019","first-page":"15","article-title":"Astragaloside iv regulates cgas-sting signaling pathway to alleviate immunosuppression caused by PRRSV infection","author":"Song","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.phymed.2025.157308_bib0020","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.virol.2010.12.045","article-title":"Complement and viral pathogenesis","volume":"411","author":"Stoermer","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.phymed.2025.157308_bib0021","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2025.157308_bib0022","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1177\/147323000903700308","article-title":"Clinical and experimental effectiveness of astragali compound in the treatment of chronic viral hepatitis b","volume":"37","author":"Tang","year":"2009","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.phymed.2025.157308_bib0023","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.3748\/wjg.v27.i21.2727","article-title":"Toward a new era of hepatitis b virus therapeutics: the pursuit of a functional cure","volume":"27","author":"Tsounis","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phymed.2025.157308_bib0024","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-1759(94)90012-4","article-title":"Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications","volume":"174","author":"Van Rooijen","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.phymed.2025.157308_bib0025","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.7150\/ijbs.57681","article-title":"Accelerated bone regeneration by astragaloside iv through stimulating the coupling of osteogenesis and angiogenesis","volume":"17","author":"Wang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phymed.2025.157308_bib0026","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1248\/bpb.32.132","article-title":"Anti-hepatitis b virus activities of astragaloside iv isolated from radix astragali","volume":"32","author":"Wang","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phymed.2025.157308_bib0027","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1038\/s41467-023-43078-5","article-title":"Interferon stimulated immune profile changes in a humanized mouse model of hbv infection","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2025.157308_bib0028","unstructured":"Who. Global hepatitis report 2024: Action for access in low- and middle-income countries [Online]. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240091672 [Accessed]."},{"key":"10.1016\/j.phymed.2025.157308_bib0029","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2021.11.024","article-title":"How to achieve functional cure of hbv: stopping nucs, adding interferon or new drug development?","volume":"76","author":"Wong","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2025.157308_bib0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12951-025-03260-x","article-title":"Astragaloside iv- loaded biomimetic nanoparticles target i\u03bab\u03b1 to regulate neutrophil extracellular trap formation for sepsis therapy","volume":"23","author":"Wu","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.phymed.2025.157308_bib0031","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cmi.2013.43","article-title":"A mouse model for hbv immunotolerance and immunotherapy","volume":"11","author":"Yang","year":"2014","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.phymed.2025.157308_bib0032","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/01.fjc.0000199683.43448.64","article-title":"Astragaloside iv exerts antiviral effects against coxsackievirus b3 by upregulating interferon-gamma","volume":"47","author":"Zhang","year":"2006","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.phymed.2025.157308_bib0033","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s11658-019-0164-y","article-title":"Progress in research on paclitaxel and tumor immunotherapy","volume":"24","author":"Zhu","year":"2019","journal-title":"Cell Mol. Biol. Lett."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S094471132500947X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S094471132500947X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:22:43Z","timestamp":1773152563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S094471132500947X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":33,"alternative-id":["S094471132500947X"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157308","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Astragaloside IV reduces hepatitis B surface antigen level via monocyte\/macrophages in chronic HBV infection mice","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157308"}}